HomeAI · summaries
Storia in 4 fonti
Peptide exceptionalism is a dangerous FDA loophole
If a compound is powerful enough to treat disease, alter metabolism, or change human physiology, it is powerful enough to harm.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
The smart way to regulate the peptide boom
“The FDA should pursue a structured, clinician-guided framework” on popular peptides, writes former surgeon general Jerome Adams.
- ·
washingtonexaminer.com
Peptide exceptionalism is a dangerous FDA loophole
If a compound is powerful enough to treat disease, alter metabolism, or change human physiology, it is powerful enough to harm.
- ·
benzinga.com
FDA Advisory Panel to Assess Peptide Bulk Drug Substances from Obesity to Opioid
FDA will review BPC-157, TB-500, Semax, and other peptides in July as it considers additions to the 503A Bulks List.
- ·
npr.org
What's behind the push to make peptide therapies more readily available
Marketed for longevity and wellness benefits, the unproven therapies are sold through a grey market online. Compounding pharmacies say they should be able to make them legally to…